Stay updated on Augmenting TRD with Allopregnanolone Analog Clinical Trial
Sign up to get notified when there's something new on the Augmenting TRD with Allopregnanolone Analog Clinical Trial page.

Latest updates to the Augmenting TRD with Allopregnanolone Analog Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedA revision update from v3.4.1 to v3.4.2 was observed on the page. No substantive content or results appear to be affected in the visible sections.SummaryDifference0.1%

- Check15 days agoChange DetectedSite revision updated to v3.4.1 and the old funding notice and Revision: v3.4.0 were removed; these are administrative updates affecting only the site banner and underlying framework. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check22 days agoChange DetectedTop-of-page banner informs users that a lapse in government funding may affect updates and transactions, with guidance to check cc.nih.gov and opm.gov for status. It also states that the NIH Clinical Center is open.SummaryDifference0.3%

- Check29 days agoChange DetectedA glossary toggle was added and QC metadata such as submission dates and software revision (v3.4.0) is now displayed; a No FEAR Act data label was adjusted.SummaryDifference0.5%

- Check36 days agoChange DetectedThe page update consists solely of updating the revision label from v3.3.3 to v3.3.4; the study results content and layout remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check65 days agoChange DetectedFooter now shows Revision: v3.3.3; the HHS Vulnerability Disclosure link and Revision: v3.3.2 were removed.SummaryDifference0.1%

Stay in the know with updates to Augmenting TRD with Allopregnanolone Analog Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Augmenting TRD with Allopregnanolone Analog Clinical Trial page.